InvestorsHub Logo
Followers 10
Posts 174
Boards Moderated 0
Alias Born 10/30/2020

Re: None

Tuesday, 03/02/2021 9:47:57 PM

Tuesday, March 02, 2021 9:47:57 PM

Post# of 198829
A few highlights from our website - My comment is: WAUW!!

This Enzolytics anti-HIV treatment is now being advanced through the certification stage, after which it will be available for patient therapy. ITV-1 also has also demonstrated a positive effect on different kinds of cancer due to its ability to stimulates the immune system.

The Company is in the final development of the recombinant of the parent antibody (identified as “Clone 3”) which has been shown in in vitro tests conduction in 5 international laboratories to fully neutralized over 95% of all strains and viral subtypes of HIV-1 against which it was tested.

Production of these monoclonal antibodies is being conducted in the Company’s lab at the Texas A&M University Institute for Preclinical Studies in College Station, Texas.